Clinical trial Recruiting at 1 site Interventional Ages 22 and up

Targeted spinal cord stimulation to reduce spasticity in spinal cord injury

Official title: Pilot Study: Addressing Spasticity and Motor Function With Epidural Spinal Cord Stimulation

Run by Kessler Foundation · NCT07890558 · Data updated 2026-11-12

This study tests whether an implanted epidural stimulator can help reduce severe spasticity and improve voluntary movement in adults with spinal cord injury.

Quick facts

Study typeInterventional
Ages22 Years and up
SexAll
Enrollment8 (estimated)
SponsorKessler Foundation
Academic / other
Locations1 site (West Orange, New Jersey)
StatusRecruiting
StartedOctober 1, 2026
Main results expectedJanuary 30, 2029
Study endsMarch 30, 2029
Registry record updatedOctober 22, 2026
Trial IDNCT07890558 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Adults 22 years or older with a documented stable spinal cord injury for at least 1 year and severe spasticity not adequately controlled by medications.

Probably not a fit

Patients without responsive neural modulation or with contraindications to implantation may not experience benefit and could face procedure-related risks.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

The trial investigates the safety and potential benefits of a surgically implanted epidural spinal cord stimulation device to treat severe spasticity in people with chronic spinal cord injury. Participants receive targeted tonic stimulation around the spinal cord and are monitored for changes in spasticity and voluntary motor control, with the goal of improving function and quality of life. Recruitment is limited to adults with stable, non-progressive SCI and inadequately controlled spasticity despite other treatments. The study emphasizes careful medical screening, device considerations, and follow-up assessments to understand the neuromodulation effects and potential rehabilitation gains.

Why it matters

Potential benefit: If successful, participants may experience reduced spasticity and better voluntary movement, potentially enabling improved participation in rehabilitation and daily activities.

How similar studies have gone: Prior neuromodulation approaches have shown potential in reducing spasticity in SCI, but this targeted SP-scES approach is continuing to explore efficacy.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

1. At least 22 years of age
2. Post 1 year non-progressive SCI
3. Stable medical condition (cleared by the study physician and do not have any medical conditions that would interfere with study procedures)
4. Diagnosed with and treated for severe spasticity at least 6 months ago

Exclusion Criteria:

1. ventilator dependent
2. untreated painful musculoskeletal dysfunction, fracture or pressure injury
3. untreated psychiatric disorder or ongoing drug abuse
4. cardiac, respiratory, bladder, renal or other untreated medical disorder unrelated to SCI
5. Botulinum toxin injections (such as Botox) or other injections to manage spasms (such as phenol or alcohol) in any muscle or bladder less than 6 months prior to implant
6. colostomy bag, urostomy
7. Any active implantable devices or implanted pump (such as a baclofen pump, pain pump, etc.)
8. pregnant at the time of enrollment or planning to become pregnant during the time course of the study
9. Contraindications to MRI imaging (e.g., pacemaker, metallic foreign body, aneurysm clip)
10. Imaging findings that determine the area of spine the stimulation device would be implanted is not suitable for surgery (such as implanted hardware interference or additional deterioration/injury of spinal cord at or below the region)
11. Severe muscle contractures
12. unable to operate a touch screen

Where it's running

  • Kessler Foundation
    West Orange, New Jersey, United States
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.